908 related articles for article (PubMed ID: 16685192)
1. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
Duprez DA
J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
[TBL] [Abstract][Full Text] [Related]
2. [The renin-angiotensin system].
Hilgers KF
Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
[No Abstract] [Full Text] [Related]
3. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
4. Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data.
Hillaert MA; Lentjes EG; Beygui F; Kemperman H; Asselbergs FW; Nathoe HM; Agostoni P; Voskuil M; Ivanes F; Jude B; Bertrand ME; Pasterkamp G; van der Graaf Y; Doevendans PA; Montalescot G; Van Belle E
Am Heart J; 2011 Oct; 162(4):585-96. PubMed ID: 21982648
[TBL] [Abstract][Full Text] [Related]
5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
6. Arterial stiffness and the renin-angiotensin-aldosterone system.
Mahmud A; Feely J
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
Turgut F; Balogun RA; Abdel-Rahman EM
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1330-9. PubMed ID: 20498247
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
9. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
10. Essential hypertension: is there a role for inflammatory mechanisms?
Androulakis ES; Tousoulis D; Papageorgiou N; Tsioufis C; Kallikazaros I; Stefanadis C
Cardiol Rev; 2009; 17(5):216-21. PubMed ID: 19690472
[TBL] [Abstract][Full Text] [Related]
11. [Renin-angiotensin-aldosterone system (RAAS) and its pharmacologic modulation].
Giestas A; Palma I; Ramos MH
Acta Med Port; 2010; 23(4):677-88. PubMed ID: 20687997
[TBL] [Abstract][Full Text] [Related]
12. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
13. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
Karalliedde J; Viberti G
J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
[TBL] [Abstract][Full Text] [Related]
14. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
15. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
16. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
18. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
Sciarretta S; Paneni F; Palano F; Chin D; Tocci G; Rubattu S; Volpe M
Clin Sci (Lond); 2009 Mar; 116(6):467-77. PubMed ID: 19200056
[TBL] [Abstract][Full Text] [Related]
19. A clinical approach in regression of glomerulosclerosis.
Stoian M; Radulian G; Chiţac D; Simion E; Stoica V
Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
[TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin system in vascular inflammation.
Marchesi C; Paradis P; Schiffrin EL
Trends Pharmacol Sci; 2008 Jul; 29(7):367-74. PubMed ID: 18579222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
